Open AccessInflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
Author(s) -
Sühendan Ekmekçioglu,
Michael A. Davies,
Keiji Tanese,
Jason Roszik,
Myung Shin-Sim,
Roland L. Bassett,
Denái R. Milton,
Scott E. Woodman,
Víctor G. Prieto,
Jeffrey E. Gershenwald,
Donald L. Morton,
Dave S.�B. Hoon,
Elizabeth A. Grimm
Publication year - 2016
Publication title -
clinical cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.427
H-Index - 324
eISSN - 1557-3265
pISSN - 1078-0432
DOI - 10.1158/1078-0432.ccr-15-2226
Subject(s) - melanoma , stage (stratigraphy) , cd74 , cancer research , medicine , expression (computer science) , biology , oncology , immunology , immune system , t cell , mhc class ii , computer science , programming language , paleontology
Inflammatory marker expression in stage III melanoma tumors was evaluated for association with outcome, using two independent cohorts of stage III melanoma patients' tumor tissues.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom